Nanhua Non Currrent Assets Other vs Deferred Long Term Liab Analysis

000504 Stock

10.30 0.12 1.15%

Nanhua Bio financial indicator trend analysis is infinitely more than just investigating Nanhua Bio Medicine recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nanhua Bio Medicine is a good investment. Please check the relationship between Nanhua Bio Non Currrent Assets Other and its Deferred Long Term Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Nanhua Bio Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Non Currrent Assets Other vs Deferred Long Term Liab

Non Currrent Assets Other vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nanhua Bio Medicine Non Currrent Assets Other account and Deferred Long Term Liab. At this time, the significance of the direction appears to have pay attention.

The correlation between Nanhua Bio's Non Currrent Assets Other and Deferred Long Term Liab is -0.72. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Nanhua Bio Medicine, assuming nothing else is changed. The correlation between historical values of Nanhua Bio's Non Currrent Assets Other and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Nanhua Bio Medicine are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Non Currrent Assets Other i.e., Nanhua Bio's Non Currrent Assets Other and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

-0.72

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Nanhua Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nanhua Bio Medicine current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Nanhua Bio Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

The current year's Tax Provision is expected to grow to about 3.2 M, whereas Selling General Administrative is forecasted to decline to about 43 M.

	2021	2022	2023	2024 (projected)
Cost Of Revenue	45.7M	70.5M	43.7M	69.4M
Total Revenue	156.6M	200.3M	136.8M	117.7M

Cost Of Revenue Total Revenue

Nanhua Bio fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Cash	Net Receivables	Short Term Investments	Inventory	Other Current Assets	Total Liab	Common Stock	Property Plant Equipment	Other Assets	Intangible Assets	Retained Earnings	Net Tangible Assets	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Good Will	Non Current Liabilities Total	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets
Total Assets		0.16	0.79	0.6	-0.13	0.91	0.76	0.77	0.22	0.37	0.37	0.79	-0.62	0.17	-0.28	-0.41	-0.04	0.57	-0.17	-0.55	0.0	-0.58	0.53	0.73	-0.69	0.78
Other Current Liab	0.16		0.45	-0.12	-0.17	0.31	-0.19	0.54	-0.08	-0.03	0.57	0.45	0.31	0.21	0.02	-0.07	0.09	0.22	0.05	-0.16	-0.2	-0.19	0.27	0.35	-0.2	0.28
Total Current Liabilities	0.79	0.45		0.17	-0.02	0.9	0.52	0.88	-0.21	0.02	0.64	1.0	-0.19	-0.07	-0.29	-0.61	-0.26	0.61	-0.09	-0.56	0.0	-0.52	0.61	0.86	-0.76	0.89
Total Stockholder Equity	0.6	-0.12	0.17		-0.41	0.32	0.43	0.33	0.76	0.65	-0.16	0.16	-0.47	0.6	-0.12	0.3	0.49	0.16	-0.26	-0.1	-0.11	-0.32	0.03	0.2	-0.09	0.31
Other Liab	-0.13	-0.17	-0.02	-0.41		-0.08	-0.06	-0.19	-0.37	-0.11	-0.05	-0.01	0.11	-0.21	0.22	-0.11	-0.28	-0.33	0.46	-0.15	0.09	0.43	0.04	0.01	-0.1	-0.16
Accounts Payable	0.91	0.31	0.9	0.32	-0.08		0.76	0.8	-0.05	0.07	0.47	0.9	-0.55	-0.01	-0.2	-0.61	-0.27	0.65	-0.16	-0.61	-0.06	-0.65	0.63	0.86	-0.74	0.88
Cash	0.76	-0.19	0.52	0.43	-0.06	0.76		0.29	-0.05	-0.08	-0.03	0.53	-0.88	-0.13	-0.05	-0.6	-0.46	0.53	-0.15	-0.49	0.05	-0.64	0.55	0.71	-0.54	0.71
Net Receivables	0.77	0.54	0.88	0.33	-0.19	0.8	0.29		0.12	0.31	0.72	0.86	-0.09	0.2	-0.31	-0.32	0.12	0.59	-0.3	-0.53	-0.2	-0.52	0.32	0.64	-0.7	0.75
Short Term Investments	0.22	-0.08	-0.21	0.76	-0.37	-0.05	-0.05	0.12		0.84	-0.32	-0.22	-0.13	0.82	-0.16	0.72	0.88	-0.18	-0.11	0.23	-0.1	0.04	-0.19	-0.26	0.35	-0.22
Inventory	0.37	-0.03	0.02	0.65	-0.11	0.07	-0.08	0.31	0.84		-0.06	0.02	0.0	0.7	-0.39	0.58	0.83	-0.14	0.12	0.05	0.08	0.16	-0.03	-0.11	0.06	-0.13
Other Current Assets	0.37	0.57	0.64	-0.16	-0.05	0.47	-0.03	0.72	-0.32	-0.06		0.63	0.12	-0.15	-0.21	-0.4	-0.13	0.46	-0.35	-0.31	-0.11	-0.3	0.1	0.3	-0.61	0.55
Total Liab	0.79	0.45	1.0	0.16	-0.01	0.9	0.53	0.86	-0.22	0.02	0.63		-0.19	-0.07	-0.28	-0.61	-0.27	0.61	-0.06	-0.54	0.03	-0.52	0.64	0.86	-0.75	0.89
Common Stock	-0.62	0.31	-0.19	-0.47	0.11	-0.55	-0.88	-0.09	-0.13	0.0	0.12	-0.19		0.03	-0.05	0.37	0.32	-0.35	0.27	0.42	0.11	0.52	-0.24	-0.39	0.38	-0.45
Property Plant Equipment	0.17	0.21	-0.07	0.6	-0.21	-0.01	-0.13	0.2	0.82	0.7	-0.15	-0.07	0.03		-0.31	0.67	0.79	-0.16	-0.05	0.14	-0.2	0.03	-0.13	-0.11	0.25	-0.1
Other Assets	-0.28	0.02	-0.29	-0.12	0.22	-0.2	-0.05	-0.31	-0.16	-0.39	-0.21	-0.28	-0.05	-0.31		0.03	-0.26	-0.15	0.04	0.17	0.0	0.07	-0.05	-0.15	0.24	-0.16
Intangible Assets	-0.41	-0.07	-0.61	0.3	-0.11	-0.61	-0.6	-0.32	0.72	0.58	-0.4	-0.61	0.37	0.67	0.03		0.82	-0.71	0.2	0.53	-0.08	0.62	-0.48	-0.66	0.7	-0.66
Retained Earnings	-0.04	0.09	-0.26	0.49	-0.28	-0.27	-0.46	0.12	0.88	0.83	-0.13	-0.27	0.32	0.79	-0.26	0.82		-0.27	-0.04	0.4	-0.03	0.25	-0.31	-0.46	0.45	-0.39
Net Tangible Assets	0.57	0.22	0.61	0.16	-0.33	0.65	0.53	0.59	-0.18	-0.14	0.46	0.61	-0.35	-0.16	-0.15	-0.71	-0.27		-0.59	-0.31	0.12	-0.94	0.41	0.54	-0.58	0.7
Non Current Assets Total	-0.17	0.05	-0.09	-0.26	0.46	-0.16	-0.15	-0.3	-0.11	0.12	-0.35	-0.06	0.27	-0.05	0.04	0.2	-0.04	-0.59		0.11	0.39	0.67	0.41	0.06	0.23	-0.34
Non Currrent Assets Other	-0.55	-0.16	-0.56	-0.1	-0.15	-0.61	-0.49	-0.53	0.23	0.05	-0.31	-0.54	0.42	0.14	0.17	0.53	0.4	-0.31	0.11		0.56	0.37	-0.07	-0.72	0.88	-0.55
Long Term Debt	0.0	-0.2	0.0	-0.11	0.09	-0.06	0.05	-0.2	-0.1	0.08	-0.11	0.03	0.11	-0.2	0.0	-0.08	-0.03	0.12	0.39	0.56		0.11	0.61	-0.1	0.27	-0.08
Good Will	-0.58	-0.19	-0.52	-0.32	0.43	-0.65	-0.64	-0.52	0.04	0.16	-0.3	-0.52	0.52	0.03	0.07	0.62	0.25	-0.94	0.67	0.37	0.11		-0.31	-0.56	0.52	-0.71
Non Current Liabilities Total	0.53	0.27	0.61	0.03	0.04	0.63	0.55	0.32	-0.19	-0.03	0.1	0.64	-0.24	-0.13	-0.05	-0.48	-0.31	0.41	0.41	-0.07	0.61	-0.31		0.65	-0.26	0.51
Deferred Long Term Liab	0.73	0.35	0.86	0.2	0.01	0.86	0.71	0.64	-0.26	-0.11	0.3	0.86	-0.39	-0.11	-0.15	-0.66	-0.46	0.54	0.06	-0.72	-0.1	-0.56	0.65		-0.77	0.85
Short Long Term Debt	-0.69	-0.2	-0.76	-0.09	-0.1	-0.74	-0.54	-0.7	0.35	0.06	-0.61	-0.75	0.38	0.25	0.24	0.7	0.45	-0.58	0.23	0.88	0.27	0.52	-0.26	-0.77		-0.76
Total Current Assets	0.78	0.28	0.89	0.31	-0.16	0.88	0.71	0.75	-0.22	-0.13	0.55	0.89	-0.45	-0.1	-0.16	-0.66	-0.39	0.7	-0.34	-0.55	-0.08	-0.71	0.51	0.85	-0.76

Click cells to compare fundamentals

Nanhua Bio Account Relationship Matchups

Nanhua Bio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	268.3M	556.1M	659.2M	553.1M	771.4M	810.0M
Other Current Liab	51.2M	75.8M	398.0M	143.0M	11.5M	10.9M
Total Current Liabilities	149.6M	418.3M	529.0M	455.2M	452.4M	256.0M
Total Stockholder Equity	18.4M	26.6M	16.6M	13.8M	256.9M	155.6M
Other Liab	4.3M	3.4M	3.0M	3.2M	2.9M	2.8M
Accounts Payable	15.6M	60.7M	89.6M	82.0M	82.2M	86.3M
Cash	69.4M	67.0M	153.0M	218.1M	493.8M	518.5M
Net Receivables	52.7M	188.8M	202.2M	158.8M	123.2M	80.5M
Short Term Investments	961.9K	657.3K	501.8K	1.7M	1.7M	3.2M
Inventory	18.4M	14.9M	10.6M	4.5M	10.7M	20.3M
Other Current Assets	1.7M	174.5M	150.3M	5.4M	7.2M	6.9M
Total Liab	153.9M	421.7M	548.9M	473.2M	466.7M	262.8M
Property Plant Equipment	11.7M	11.6M	35.9M	35.9M	32.3M	30.4M
Other Assets	81.8M	45.8M	92.1M	86.6M	99.6M	140.9M
Intangible Assets	2.9M	1.5M	217.8K	361.3K	440.8K	418.8K
Retained Earnings	(445.0M)	(436.8M)	(455.9M)	(468.6M)	(531.1M)	(504.5M)
Net Tangible Assets	4.3M	13.8M	8.0M	5.0M	5.7M	6.0M
Non Current Assets Total	124.7M	76.4M	142.6M	136.8M	116.5M	108.6M
Non Currrent Assets Other	73.2K	3.4M	1.5M	645.1K	38.0K	36.1K
Non Current Liabilities Total	4.3M	3.4M	19.9M	18.0M	14.3M	13.5M
Deferred Long Term Liab	46.8M	41.4M	89.6M	85.7M	98.5M	59.4M
Short Long Term Debt	50.1M	13.0M	32.9M	63.1M	28.1M	53.3M
Total Current Assets	143.6M	479.7M	516.6M	416.2M	654.9M	381.0M
Net Invested Capital	68.5M	39.6M	49.6M	76.9M	285.1M	299.3M
Net Working Capital	(6.0M)	61.4M	(12.4M)	(38.9M)	202.5M	212.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Nanhua Stock

Balance Sheet is a snapshot of the financial position of Nanhua Bio Medicine at a specified time, usually calculated after every quarter, six months, or one year. Nanhua Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Nanhua Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Nanhua currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nanhua Non Currrent Assets Other vs Deferred Long Term Liab Analysis

Non Currrent Assets Other vs Deferred Long Term Liab

Non Currrent Assets Other vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Non Currrent Assets Other

Deferred Long Term Liab

Nanhua Bio fundamental ratios Correlations

Nanhua Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nanhua Bio fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Nanhua Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Current Liabilities
Accounts Payable	+ 0.91	Total Assets
Accounts Payable	+ 0.9	Total Current Liabilities
Total Liab	+ 0.9	Accounts Payable
Total Current Assets	+ 0.89	Total Current Liabilities
Total Current Assets	+ 0.89	Total Liab

Good Will	- 0.94	Net Tangible Assets
Common Stock	- 0.88	Cash
Short Long Term Debt	- 0.77	Deferred Long Term Liab
Total Current Assets	- 0.76	Short Long Term Debt
Short Long Term Debt	- 0.76	Total Current Liabilities
Short Long Term Debt	- 0.75	Total Liab